by Paul Haskins | Jun 13, 2012 | Reverse Diabetes
NEW YORK and COPENHAGEN, Denmark, June 13, 2012 — –Focus Will Be on Disease-Modifying Immunotherapies for Type 1 Diabetes– NEW YORK and COPENHAGEN, Denmark, June 13, 2012 /PRNewswire-USNewswire/ — To address the underlying autoimmune process...
by Paul Haskins | Jun 12, 2012 | Reverse Diabetes
PHILADELPHIA, PA, Jun 11, 2012 (MARKETWIRE via COMTEX) — Three major studies examining long-acting insulin use in the U.S. and Europe found no increased risk of a wide range of cancers in patients using glargine, contradicting previous suggestions that there may...
by Paul Haskins | Jun 12, 2012 | Reverse Diabetes
Attorney Thomas Henson Jr. (right) has chaired the North Carolina Tour de Cure for the past three years. The HensonFuerst team has been the Tour de Cure team during the last five years. It is incredible how they outdo themselves when it comes to riders, fundraising,...
by Paul Haskins | Jun 11, 2012 | Reverse Diabetes
PHILADELPHIA, PA, Jun 11, 2012 (MARKETWIRE via COMTEX) — In a modern-day clinical trial of a medicine belonging to one of the world’s oldest classes of drugs, researchers have found that a drug related to aspirin and salicylate, which was first used by...
by Paul Haskins | Jun 10, 2012 | Reverse Diabetes
Raleigh, N.C. — Heading to New York City and across the country, some local bicyclists are riding extreme distances to find a cure for Type 1 diabetes, also called juvenile diabetes.Jimmy Dodson has included an insulin pump and glucose monitor as part of his biking...
by Paul Haskins | Jun 9, 2012 | Reverse Diabetes
PHILADELPHIA, PA, Jun 09, 2012 (MARKETWIRE via COMTEX) — Children diagnosed with type 2 diabetes appear to experience a more rapidly progressive disease than people who are diagnosed as adults, with a higher rate of early complications and a relatively early...
